Sectoral Asset Management Inc Fibrogen Inc Transaction History

Sectoral Asset Management Inc

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 14, 2021	SELL	$31.0 - $55.72 $3.22 Million - $5.79 Million	-104,000 Closed	0 $0
Q3 2020 Nov 13, 2020	BUY	$40.47 - $45.5 $3.69 Million - $4.15 Million	91,300 Added 718.9%	104,000 $4.28 Million
Q2 2020 Aug 13, 2020	SELL	$32.57 - $42.83 $10.5 Million - $13.8 Million	-322,806 Reduced 96.21%	12,700 $515,000
Q1 2020 May 13, 2020	SELL	$23.3 - $45.96 $729,290 - $1.44 Million	-31,300 Reduced 8.53%	335,506 $11.7 Million
Q4 2019 Feb 12, 2020	BUY	$34.58 - $48.06 $1.15 Million - $1.6 Million	33,346 Added 10.0%	366,806 $15.7 Million
Q3 2019 Nov 14, 2019	BUY	$36.98 - $48.45 $1.14 Million - $1.49 Million	30,800 Added 10.18%	333,460 $12.3 Million
Q2 2019 Aug 14, 2019	BUY	$35.13 - $55.53 $7.78 Million - $12.3 Million	221,400 Added 272.46%	302,660 $13.7 Million
Q1 2019 May 14, 2019	BUY	$42.83 - $59.91 $3.48 Million - $4.87 Million	81,260 New	81,260 $4.42 Million

47.1M

387K

672K

Ticker FGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 93,741,200
Market Cap $54.4M
Description
FibroGen, Inc., a biopharmaceutical company, discovers, develops, and commercializes therapeutics to treat serious unmet medical needs. The company is developing Roxadustat, an oral small molecule inhibitor of hypoxia inducible factor prolyl hydroxylases, which has completed Phase III clinical development for the treatment of anemia in chronic k...

Get notified when there are updates to the investment portfolio of Sectoral Asset Management Inc, based on Form 13F filings with the SEC.

Stay updated on Sectoral Asset Management Inc with notifications on news.